Apollomics APLM
NASDAQ APLM
$23.86 -1.02 (-4.04%)
As of: Sep 10, 2026 · 11:04 AM EDT

Apollomics (APLM) Total Liabilities (2021 - 2025)

Apollomics' (APLM) quarterly Total Liabilities came in at $7.0 million in Q4 2025, up 7256.84% year-over-year from $95000.0 in Q4 2024, and up 1425.98% quarter-over-quarter from $458000.0 in Q2 2025.

Analysis

Apollomics (APLM) Total Liabilities (2021 - 2025) Analysis & Trends

Apollomics (APLM) has reported Total Liabilities for 5 consecutive years, with $7.0 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Total Liabilities rose 7256.84% year-over-year to $7.0 million in Q4 2025; TTM through Dec 2025 was $7.0 million, a 7256.84% increase from a year earlier, with the FY2025 full-year figure at $7.0 million, up 7256.84% from the prior year.
  • Total Liabilities was $7.0 million for Q4 2025 at Apollomics, up from $458000.0 in the prior quarter.
  • Over five years, Total Liabilities peaked at $448.1 million in Q4 2022 and troughed at $95000.0 in Q4 2024.
  • A 5-year average of $121.4 million and a median of $7.0 million in 2025 frame the typical range for Total Liabilities.
  • Across the five-year window, Total Liabilities slumped 99.94% in 2023 and jumped 7256.84% in 2025, its largest moves.
  • Over 5 years, Total Liabilities stood at $322.2 million in 2021, then soared by 39.07% to $448.1 million in 2022, then tumbled by 99.94% to $259000.0 in 2023, then sank by 63.32% to $95000.0 in 2024, then jumped by 7256.84% to $7.0 million in 2025.
  • The last three Total Liabilities figures came in at $7.0 million (Q4 2025), $458000.0 (Q2 2025), and $95000.0 (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 83.95 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 37.53 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 7.18 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 10.02 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.62 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 4.20 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 4.20 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 13.24 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 384.62 Mn
10 Apollomics 34.50 Mn 31.23 Mn - 6.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 6.99 Mn
Jun 30, 2025 458,000.00
Dec 31, 2024 95,000.00
Jun 30, 2024 145,000.00
Dec 31, 2023 259,000.00
Jun 30, 2023 15.68 Mn
Dec 31, 2022 448.12 Mn
Jun 30, 2022 298.55 Mn
Dec 31, 2021 322.22 Mn